…
Paranovus Entertainment Technology Ltd. engages in the research, development, manufacture, and sale of nutraceutical and dietary supplement products in the People's Republic of China and internationally. The company's product category includes lucidum spore powders, cordyceps mycelia, Ejiao products, American ginseng products, other traditional Chinese herbal and animal extracts, vitamins, minerals, and amino acids. It also offers product marketing and e-commerce agency operation services under the Happy Buy platform to small and middle size businesses; and e-commerce solutions, internet information, and advertising services to the online stores or manufactures. In addition, the company provides secure transaction environment, automobile procurement, and financial services for automobile manufacturers under the Taochejun automobile sales platform. It sells its products through distributors, large-scale chain drugstores, malls, and supermarkets under the Happiness brand. The company was formerly known as Happiness Development Group Limited and changed its name to Paranovus Entertainment Technology Ltd. in March 2023. The company was founded in 2004 and is headquartered in Nanping, the People's Republic of China.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Public disclosures for Paranovus Entertainment Technology Ltd are limited; it is described as an entertainment-technology company. Long-term growth may be supported by rising consumer adoption of digital entertainment and virtual experiences, making it an early-stage exposure for investors seeking upside.
Key risks are sparse disclosure, low liquidity, limited operating history with execution and financing risk, and sensitivity to shifting technology and regulation.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2023-03-31 | 2022-03-31 | 2021-03-31 | 2020-03-31 | 2019-03-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-03-31 | 2022-03-31 | 2021-03-31 | 2020-03-31 | 2019-03-31 |
| Income before tax | -68.73M | -57.75M | 1.65M | 15.53M | 21.91M |
| Minority interest | 0.45M | 4.83M | - | - | - |
| Net income | -71.74M | -49.19M | 0.69M | 12.69M | 18.72M |
| Selling general administrative | 9.48M | 9.13M | 5.03M | 3.48M | 1.95M |
| Selling and marketing expenses | 54.70M | 40.48M | 9.96M | 9.18M | 6.29M |
| Gross profit | 5.05M | 3.71M | 18.18M | 30.42M | 32.25M |
| Reconciled depreciation | 3.38M | 2.19M | 0.88M | 0.69M | 0.70M |
| Ebit | -60.79M | -47.35M | 1.76M | 15.63M | 21.99M |
| Ebitda | -57.41M | -45.16M | 2.64M | 16.32M | 22.69M |
| Depreciation and amortization | 3.38M | 2.19M | 0.88M | 0.69M | 0.70M |
| Operating income | -68.39M | -57.89M | 1.53M | 15.40M | 21.84M |
| Other operating expenses | 158.67M | 137.06M | 69.96M | 49.66M | 42.09M |
| Interest expense | 0.07M | 0.09M | 0.11M | 0.10M | 0.08M |
| Tax provision | 3.46M | -3.73M | 0.96M | 2.84M | 3.18M |
| Interest income | 0.03M | 0.11M | 0.13M | 0.07M | 0.04M |
| Net interest income | -0.04M | 0.02M | 0.02M | -0.02M | -0.04M |
| Income tax expense | 3.46M | -3.73M | 0.96M | 2.84M | 3.18M |
| Total revenue | 98.15M | 89.49M | 71.48M | 65.06M | 63.94M |
| Total operating expenses | 65.58M | 51.29M | 16.65M | 15.02M | 10.40M |
| Cost of revenue | 93.10M | 85.78M | 53.31M | 34.64M | 31.69M |
| Total other income expense net | -8.17M | -10.19M | 0.11M | 0.16M | 0.10M |
| Net income from continuing ops | -72.19M | -54.02M | 0.69M | 12.69M | 18.72M |
| Net income applicable to common shares | - | -49.19M | 0.79M | 12.69M | - |
| Breakdown | 2023-03-31 | 2022-03-31 | 2021-03-31 | 2020-03-31 | 2019-03-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-03-31 | 2022-03-31 | 2021-03-31 | 2020-03-31 | 2019-03-31 |
| Total assets | 36.34M | 97.43M | 112.74M | 85.10M | 65.68M |
| Intangible assets | 9.45M | 10.10M | 1.83M | 0.72M | 0.77M |
| Other current assets | 0.26M | 0.23M | 12.86M | 0.70M | 6.05M |
| Total liab | 22.47M | 20.01M | 15.11M | 5.51M | 4.76M |
| Total stockholder equity | 14.76M | 78.13M | 94.75M | 79.59M | 60.92M |
| Other current liab | 0.38M | 3.51M | 4.03M | 1.93M | 2.06M |
| Common stock | 0.08M | 0.04M | 0.02M | 0.01M | 0.01M |
| Capital stock | 0.08M | 0.04M | 0.02M | 0.01M | 0.01M |
| Retained earnings | -59.45M | 12.29M | 61.48M | 66.62M | 53.94M |
| Other liab | - | 2.08M | - | - | - |
| Good will | 6.46M | 10.08M | 0.16M | - | - |
| Other assets | - | 9.42M | 5.14M | 6.50M | - |
| Cash | 3.36M | 19.73M | 36.56M | 33.65M | 14.80M |
| Total current liabilities | 20.95M | 17.93M | 15.11M | 5.51M | 4.76M |
| Current deferred revenue | 5.06M | - | - | - | - |
| Net debt | -1.11M | -17.47M | -34.32M | -31.62M | -13.76M |
| Short term debt | 2.24M | 2.27M | 2.24M | 2.03M | 1.04M |
| Short long term debt | 2.24M | 2.27M | 2.24M | 2.03M | 1.04M |
| Short long term debt total | 2.24M | 2.27M | 2.24M | 2.03M | 1.04M |
| Other stockholder equity | 66.91M | 53.87M | 26.55M | 15.04M | 5.70M |
| Property plant equipment | - | 11.25M | 10.51M | 7.90M | - |
| Total current assets | 9.79M | 56.57M | 95.10M | 69.98M | 54.84M |
| Net tangible assets | - | 57.94M | 92.75M | 78.87M | - |
| Net receivables | 3.96M | 29.23M | 34.56M | 30.04M | 32.02M |
| Inventory | 0.34M | 1.39M | 1.79M | 2.03M | 1.97M |
| Accounts payable | 13.46M | 12.16M | 8.84M | 1.55M | 1.66M |
| Accumulated other comprehensive income | 7.22M | 11.93M | 6.71M | -2.09M | 1.27M |
| Non currrent assets other | 2.18M | 5.63M | 5.14M | 6.50M | 2.26M |
| Non current assets total | 26.55M | 40.86M | 17.65M | 15.11M | 10.84M |
| Breakdown | 2023-03-31 | 2022-03-31 | 2021-03-31 | 2020-03-31 | 2019-03-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-03-31 | 2022-03-31 | 2021-03-31 | 2020-03-31 | 2019-03-31 |
| Investments | 0.09M | -8.48M | -13.22M | -1.16M | -0.28M |
| Change to liabilities | - | -4.85M | 6.72M | -0.03M | - |
| Total cashflows from investing activities | - | -8.48M | -13.22M | -1.16M | - |
| Net borrowings | - | -0.05M | 0.04M | 1.06M | - |
| Total cash from financing activities | 3.15M | 18.83M | 10.67M | 10.40M | 0.27M |
| Change to operating activities | - | -3.38M | -4.05M | -2.47M | - |
| Net income | -72.19M | -54.02M | 0.69M | 12.69M | 18.72M |
| Change in cash | -16.38M | -16.83M | 2.90M | 18.85M | 5.92M |
| Begin period cash flow | 19.73M | 36.56M | 33.65M | 14.80M | 8.88M |
| End period cash flow | 3.36M | 19.73M | 36.56M | 33.65M | 14.80M |
| Total cash from operating activities | -21.09M | -28.13M | 2.90M | 10.78M | 6.54M |
| Issuance of capital stock | 3.00M | 18.88M | 10.97M | 9.34M | - |
| Depreciation | 3.38M | 2.19M | 0.88M | 0.69M | 0.70M |
| Other cashflows from investing activities | - | 1.93M | 1.93M | 1.93M | - |
| Dividends paid | 0.00M | 0.00M | 0.38M | - | 0.00M |
| Change to inventory | 1.05M | 0.45M | 0.39M | -0.28M | 0.15M |
| Change to account receivables | 24.89M | 23.22M | -2.11M | 0.39M | -1.60M |
| Sale purchase of stock | - | - | 2.16M | - | - |
| Other cashflows from financing activities | 2.49M | 2.25M | 2.20M | 3.13M | 2.02M |
| Change to netincome | - | 3.74M | 0.68M | 0.12M | - |
| Capital expenditures | 0.05M | 2.41M | 3.83M | 1.16M | 0.28M |
| Change in working capital | 36.05M | 15.13M | 0.55M | -2.72M | -12.87M |
| Stock based compensation | 0.00M | 1.09M | 0.78M | - | - |
| Other non cash items | 8.44M | 22.80M | - | 0.12M | -0.00M |
| Free cash flow | -21.14M | -30.54M | -0.93M | 9.62M | 6.26M |
Sector: Consumer Defensive Industry: Packaged Foods
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| PAVS Paranovus Entertainment Technology Ltd. |
-0.41 13.58% |
2.61 | - | - | 0.11 | 0.92 | 0.10 | -0.16 |
| NSRGF Nestle SA |
- -% |
103.52 | 26.86 | 18.76 | 3.13 | 7.10 | 3.81 | 21.70 |
| NSRGY Nestle SA ADR |
-0.59 0.56% |
104.96 | 26.82 | 18.66 | 3.18 | 7.07 | 3.81 | 21.70 |
| DANOY Danone PK |
0.01 0.07% |
15.29 | 24.23 | 17.64 | 1.88 | 2.57 | 1.88 | 11.70 |
| GPDNF Danone S.A |
- -% |
75.55 | 20.30 | 14.75 | 1.65 | 2.24 | 1.76 | 10.92 |
Paranovus Entertainment Technology Ltd. engages in the research, development, manufacture, and sale of nutraceutical and dietary supplement products in the People's Republic of China and internationally. The company's product category includes lucidum spore powders, cordyceps mycelia, Ejiao products, American ginseng products, other traditional Chinese herbal and animal extracts, vitamins, minerals, and amino acids. It also offers product marketing and e-commerce agency operation services under the Happy Buy platform to small and middle size businesses; and e-commerce solutions, internet information, and advertising services to the online stores or manufactures. In addition, the company provides secure transaction environment, automobile procurement, and financial services for automobile manufacturers under the Taochejun automobile sales platform. It sells its products through distributors, large-scale chain drugstores, malls, and supermarkets under the Happiness brand. The company was formerly known as Happiness Development Group Limited and changed its name to Paranovus Entertainment Technology Ltd. in March 2023. The company was founded in 2004 and is headquartered in Nanping, the People's Republic of China.
| Name | Title | Year Born |
|---|---|---|
| Mr. Xuezhu Wang | Chairman & CEO | 1985 |
| Ms. Ye Tao CFA | CFO & Director | 1978 |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.